News
Article
Author(s):
ICYMI, this week we had stories about counting down to Fall Clinical in Vegas, clascoterone cream 1% for acne vulgaris management, VP-315 for basal cell carcinoma lesions, and more.
Dermatology Times is counting down to the annual Fall Clinical conference in Las Vegas, Nevada, with our top 5 headlines and highlights from this year's PA and NP summer conference.
In part 1 of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD, discuss the pathogenesis of acne vulgaris, the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.
Dermatology Times Editor in Chief Zoe Diana Draelos, MD, reflects on the importance of dermatology residency programs in cultivating early passion for the specialty.
This Hair Loss Awareness Month, test your knowledge of hair loss conditions. Click here to answer this week's poll.
Patients with episodes longer than 4 years had a delayed response rate.
Mannitol and ectoine, when used with UV filters in sunscreen, can provide a higher level of skin protection.
As your youngest patients begin the return to the classroom, pediatric dermatologist Latanya Benjamin, MD, FAAD, FAAP, offers perspectives in education and skin care tips.
Female sex bias in hidradenitis suppurativa can be attributed to several contributing immunological factors.
This week’s collection of the latest dermatologic studies covers distinguishing between granular cell tumors and melanoma, methotrexate and biologics for anxiety and depression among PsO patients, botulinum toxin for scalp conditions, and a review of the SPRING study for guselkumab.
Piction Health Dermatology seeks to break down barriers in dermatologic care access.
The study is the first large study to assess skin cancer screening efforts aimed at volunteer firefighters in the US.
Results showed that the hybrid filler significantly increased collagen fibers with minimal adverse events.
The results showed that minoxidil with laser resulted in a slightly better dermoscopy score than minoxidil alone.
In part 2 of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; Leon Kircik, MD, discuss the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.
This Psoriasis Awareness Month, Dermatology Times is looking back at the treatment and research landscape of 2023.
In this week’s Pointers With Portela, the 208SkinDoc answers frequently asked questions about microneedling and its benefits.
While the linkage between squamous cell cancers and genital lichen sclerosus has been well-established, fewer studies have examined the associations between penile melanomas in males.
Researchers found that STAT3 could be activated, and inhibition could be achieved in patients with hypertrophic scarring.
Most of the patients receiving the non-surgical treatment experienced a complete clearing of tumors.
ABO blood type appeared to be a factor in severity of acne vulgaris.
Five nurse practitioners and physician assistants review patient case presentations and discuss unmet needs in the psoriasis landscape.
A Zurich case series is demonstrating the efficacy of dupilumab injections in patients with inflammation and chronic prurigo.
In this month's Legal Eagle, learn what clinicians are required to disclose about their personal health ahead of performing procedures.
Patients with the DecisionDx-Melanoma 31-gene expression profile test had a 29% lower melanoma-specific survival mortality.
UV exposure or trauma to the skin, such as blistering and ulceration, can lead to changes in skin pigmentation and appearance.
A combined treatment regimen of encorafenib and binimetinib led to improved progression-free survival, overall response rate, and tolerability in patients with advanced BRAF-mutant melanoma.
David Mandell, JD, MBA, is here to help ensure new and novice clinicians understand the impact of taxes, lifestyle creep, investment plans, and more.
Total dose and number of cycles of rituximab were not associated with duration or severity of COVID-19 disease.
The DERMACLEAR study has retrospectively obtained data from more than 54,000 patients, and the NLP system had greater than 95% precision.
Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.
Patient and physician demographics were not significantly associated with discordance.
Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and National Psoriasis Foundations President and CEO Leah Howard, JD, discusses the importance of advocacy and mental health in chronic skin conditions.